-
Central Banks And More Earnings
Thursday, February 2, 2023 - 11:36am | 1432Read More...Good Morning Everyone! Especially Mark Zuckerberg who stopped hanging out in the metaverse. Cut costs and returned to cash flow positive. Stock up 20% pre-market set to gain $200 billion. Next catalyst, AI? Prices as of 4 pm EST, 2/1/23; % YTD MARKET UPDATE The U.S. Federal Reserve delivered an...
-
Flowers Foods, EverCommerce, And Some Other Big Stocks Moving Lower On Friday
Friday, November 11, 2022 - 12:12pm | 461Read More...U.S. stocks traded mixed, with the Nasdaq gaining more than 100 points on Friday. Here are some big stocks recording losses in today’s session. Expensify, Inc. (NASDAQ: EXFY) dropped 19.2% to $10.46 after the company reported worse-than-expected Q3 EPS and sales results. Ryan Specialty...
-
All Is Calm Ahead Of The Federal Reserve This Afternoon
Wednesday, November 2, 2022 - 1:19pm | 1433Read More...Good Morning Everyone! Remember, today at 2pm, a group of middle-aged financial experts determines whether or not millions of Robinhood traders get margin called. Prices as of 4 pm EST, 11/1/22; % YTD MARKET UPDATE 2 p.m. Fed Reserve Rate decision Volatility is relatively LOW heading...
-
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
Wednesday, November 2, 2022 - 7:58am | 1269Read More...Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 28.8% to $23.55 in pre-market trading. Arcturus...
-
McKesson To $440? Plus This Analyst Raises PT On Fox
Wednesday, November 2, 2022 - 7:26am | 274Read More...Baird boosted the price target on McKesson Corporation (NYSE: MCK) from $405 to $440. McKesson shares fell 1.7% to $375.55 in pre-market trading. Rosenblatt raised Fox Corporation (NASDAQ: FOXA) price target from $30 to $31. Fox shares gained 5.8% to close at $30.53 on Tuesday. Raymond...
-
ZoomInfo Technologies, McKesson And This Restaurant Stock Insiders Are Selling
Thursday, October 13, 2022 - 9:23am | 523Read More...US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity...
-
McKesson Buys Rx Savings Solutions For $875M
Monday, September 19, 2022 - 11:57am | 322Read More...McKesson Corp (NYSE: MCK) has agreed to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company offering affordability and adherence solutions to health plans and employers, reaching more than 17 million current patients. The...
-
Amazon, Target And 3 Other Stocks Insiders Are Selling
Monday, September 19, 2022 - 9:17am | 817Read More...U.S. crude oil futures traded lower this morning on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity...
-
Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson
Monday, August 22, 2022 - 9:02am | 424Read More...UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading. Morgan Stanley raised the price target on McKesson Corporation (NYSE: MCK) from $370 to $403. McKesson shares fell 0.3% to $369.99 in pre-...
-
eBay To $59? Plus Goldman Sachs Predicts This PT For Costco Wholesale
Thursday, August 4, 2022 - 9:15am | 423Read More...Piper Sandler cut the price target for eBay Inc. (NASDAQ: EBAY) from $63 to $59. eBay shares rose 0.5% to $50.75 in pre-market trading. Goldman Sachs reduced the price target on Match Group, Inc. (NASDAQ: MTCH) from $105 to $80. Match Group shares rose 0.6% to $63.60 in pre-market trading....
-
McKesson Boosts FY23 Outlook Backed By Strong Contribution From COVID-19 Drugs
Thursday, August 4, 2022 - 7:40am | 275Read More...McKesson Corp (NYSE: MCK) reported Q1 FY23 adjusted EPS of $5.83, +5% Y/Y, beating the consensus of $5.27. Revenues increased 7% Y/Y to $67.15 billion, surpassing the consensus of $65.14 billion. U.S. Pharmaceutical segment's revenues were $56.9 billion, +14%, driven by an increased...
-
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report
Tuesday, July 12, 2022 - 7:50am | 386Read More...Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NYSE: TEVA) lied to evade accountability regarding its role in the state's opioid crisis. Teva was accused by Attorney General Letitia James, Nassau County, and Suffolk County of using...
-
Federal Judge Says McKesson, AmerisourceBergen, Cardinal Health Not Responsible For Opioid Epidemic: Report
Tuesday, July 5, 2022 - 7:32am | 311Read More...Federal judge David Faber rejected the efforts to force McKesson Corp (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), and Cardinal Health Inc (NYSE: CAH) to pay $2.5 billion for the opioid crisis. The judge ruled that the drug distributors are not responsible for...
-
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
Tuesday, June 28, 2022 - 9:53am | 1207Read More...The opioid crisis has raised public awareness about the dire state of pain-management options for the estimated 50 million Americans with chronic pain. As the crisis renews the call for researchers to find a pain relief method that is both powerful and safe, some pharmaceutical companies like...
-
Executives Sell Around $12M Of 3 Stocks
Tuesday, June 21, 2022 - 8:23am | 529Read More...U.S. stock futures traded higher this morning on Tuesday after recording losses in the previous week. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced...















